Production process analysis: a review of the device history record confirmed that the device was manufactured and tested according to relevant procedures, and shipped according to manufacturer's specifications.User (surgeon and patient) information analysis: patient (b)(6) index procedure was performed on (b)(6) 2019.On (b)(6) 2023, apifix was notified that patient (b)(6) is scheduled for revision surgery on (b)(6) 2023 to a new apifix device.Due to implant breakage.On (b)(6) 2023 apifix was notified that the patient underwent the revision in which a new mid-c rod and apifix screw were replaced.Patient x-rays from before and after the revision were provided.No report of patient harm/complications was receieved.The device will not be returned to the manufacturer for evaluation risk assessment: implant breakage can result from trauma, practicing contact or high demand sports, hyper-kyphosis, inserting the pedicle screws in a wrong trajectory which locks the poly-axial joints, not working according to the surgical technique (e.G., minimally invasive approach and/or not using the trial tool properly).The risk for breakage due to the above increases when the implant reaches its maximal elongation.Reoperation events are a known risk that was assessed and recorded by the product risk management file.The risk of broken rod has been assessed and found to be acceptable the current implant breakage rate due to any reason is in line with the rate reported in the literature for this type of complication as described in the company's cer (clinical evaluation report).The risk has been quantified, characterized, and documented as acceptable within a full risk assessment.If new pertinent information comes to light, then a supplemental medwatch report will be submitted.
|